| Schedule of installment payments - licenses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
|
|
Anti-Itch |
|
|
|
($in thousands) |
|
Ximino 1 |
|
Accutane 2 |
|
Product 3 |
|
Total |
Installment payments - licenses, short-term |
|
$ |
2,000 |
|
$ |
2,000 |
|
$ |
1,000 |
|
$ |
5,000 |
Less: imputed interest |
|
|
(425) |
|
|
(65) |
|
|
— |
|
|
(490) |
Sub-total installment payments - licenses, short-term |
|
$ |
1,575 |
|
$ |
1,935 |
|
$ |
1,000 |
|
$ |
4,510 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Installment payments - licenses, long-term |
|
$ |
3,000 |
|
$ |
1,000 |
|
$ |
— |
|
$ |
4,000 |
Less: imputed interest |
|
|
(350) |
|
|
(23) |
|
|
— |
|
|
(373) |
Sub-total installment payments - licenses, long-term |
|
$ |
2,650 |
|
$ |
977 |
|
$ |
— |
|
$ |
3,627 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total installment payments - licenses |
|
$ |
4,225 |
|
$ |
2,912 |
|
$ |
1,000 |
|
$ |
8,137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2020 |
|
|
|
|
|
|
|
|
Anti-Itch |
|
|
|
($in thousands) |
|
Ximino 1 |
|
Accutane 2 |
|
Product 3 |
|
Total |
Installment payments - licenses, short-term |
|
$ |
2,000 |
|
$ |
500 |
|
$ |
2,800 |
|
$ |
5,300 |
Less: imputed interest |
|
|
(602) |
|
|
(122) |
|
|
(54) |
|
|
(778) |
Sub-total installment payments - licenses, short-term |
|
$ |
1,398 |
|
$ |
378 |
|
$ |
2,746 |
|
$ |
4,522 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Installment payments - licenses, long-term |
|
$ |
5,000 |
|
$ |
3,000 |
|
$ |
1,000 |
|
$ |
9,000 |
Less: imputed interest |
|
|
(775) |
|
|
(88) |
|
|
— |
|
|
(863) |
Sub-total installment payments - licenses, long-term |
|
$ |
4,225 |
|
$ |
2,912 |
|
$ |
1,000 |
|
$ |
8,137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total installment payments - licenses |
|
$ |
5,623 |
|
$ |
3,290 |
|
$ |
3,746 |
|
$ |
12,659 |
Note 1: Imputed interest rate of 11.96% and maturity date of July 22, 2024.
Note 2: Imputed interest rate of 4.03% and maturity date of July 29, 2023.
Note 3: Imputed interest rate of 4.25% and maturity date of January 1, 2022.
|